SID&GP Director took part in the meeting dedicated to pharmaceutical manufacturing localization in the Ryazan region
On November 17, a meeting dedicated to the pharmaceutical manufacturing localization of the Swedish company Sobi was held at the “Skopinpharm” LLC site in the Ryazan region.
The meeting was attended by Svetlana Goryachkina, Deputy Prime Minister of the region, Vladislav Shestakov, Director of SID&GP, Inga Nizharadze, Head of “Skopinpharm” LLC, Yuri Zhulyov, President of the All-Russia Society of Hemophilia and heads of relevant Ministries.
The strategic partnership between the Swedish pharmaceutical company Sobi, which specializes in the drugs development to treat orphan diseases in the field of hematology and immunology, and the Russian plant “Skopinpharm” opens up new opportunities in supplying hemophilia patients. The localization of the new manufacturing will not only manufacture another innovative drug, but will also create additional job opportunities and make a significant contribution in the development of the region’s economy.
Director of State Institute of Drugs and Good Practices, Vladislav Shestakov clarified that this year “Eloctate” was registered in Russia.
“Eloctate” – drug for patients with hemophilia treatment is part of the medicines reimbursement systems of 23 countries, including the UK, Germany, Canada and France, – stated Vladislav Shestakov. – Since this year, the drug has been registered in Russia as well, which provides for our patients with hemophilia an access to innovative and effective drugs, improves their quality of life”.
President of the All-Russia Society of Hemophilia, Yuri Zhulyov noted that thanks to this project doctors have an opportunity to treat patients with hemophilia more effectively.
“It is very important that one of the oldest Russian societies of haemophiliacs has been active in Ryazan region for many years. – said Yuri Zhulyov. – Now there will be even more chances for haemophiliacs to live full lives in the Ryazan region”.
Other materials
- Attendees of the ‘Ensuring Drug Security’ Forum discussed issues of public trust in the Russian pharmaceutical products
- Vladislav Shestakov took part in the 8th International Pharmaceutical Congress Russia – Nicaragua “Evolution of Production Potential: Localization of Production to Strengthen the International Health Care System”
- The 31st N.A. Semashko Russian Pharmaceutical Forum was held in Saint Petersburg on May 14-15, 2024 with the support of the FSI “SID&GP” of the Ministry of Industry and Trade of Russia
- The expansion of cooperation in the pharmaceutical and medical industries discussed at the INNOPROM. Central Asia international exhibition
- FSI “SID&GP” participated in the workshop on “Radiopharmaceuticals: production, quality, safety in 2024”